Speaker Profile
M.D., Sr. Director Clinical Development, Moderna
Biography
Dr. Robert Meehan is an experienced pharmaceutical executive with over 10 years of leadership experience in biotechnology and pharmaceutical development. He joined Moderna in 2017 to lead the company's efforts to develop mRNAbased medicines including individualized therapies for cancer patients. Prior to joining Moderna, Dr. Meehan was a staff clinician at the National Cancer Institute in the DTC. He has authored many publications and is an inventor on multiple patents.
Session Abstract – PMWC 2024 Silicon Valley
Track 1 - January 25 9.00 A.M.-3.00 P.M.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Scientific Advancements in Individualized Cell Therapeutics for Oncology( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- George Coukos, Ludwig Institute for Cancer Research
- Bobert Meehan, Moderna - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: TBA
- Amanda Pace, Sonoma Bio - AI-Enhanced Approaches in Gene-Modified Cell Therapy Development
Chair: TBA
- Brian Weitzner, Outpace Bio
- Richard Bonneau, Prescient Design
